Medical Malpractice Lawyers Will Help Defend Your Birth Injury Case

Attorney Alvin de Levie in the Courtroom

The Law Offices of Alvin F. de Levie & Associates

Looking into the eyes of parents whose child has been injured or hurt is one of the most difficult things thatI ever faced. I just have to help these people

Looking into the eyes of a parent whose child has been inmjured or hurt is one of the most difficult things that I have ever faced. I just have to help these people and fortunately I can and do!”

— Alvin de Levie, Esq.


Medical Malpractice Lawyers Defend Birth Injuries: Erb's Palsy and Klumpke's Palsy

Erb's Palsy and Klumpke's Palsy are birth injuries commonly associated with Shoulder Dystocia. Shoulder dystocia is a term used to describe a birth situation where the child's shoulder gets caught behind the mother's pelvic bone during birth. Shoulder dystocia places the child at a high risk for serious and fatal injuries and must be treated immediately.

To deliver the child, a doctor must maneuver the child to free the shoulder from the pelvic bone. Unfortunately, doctor's occasionally applied excessive force and make use of improper techniques while delivering the child resulting in a birth injury.

This can cause injury to the brachial plexus – the network of five nerves running from the child's spine in the neck to the shoulder, arms and hand. Depending on the severity of the injury and which nerves were damaged, brachial plexus injuries can lead to both Erb’s Palsy and Klumpke's Palsy. This is considered a form of medical malpractice.

What is Erb's Palsy?

Erb's Palsy is a form of paralysis which develops when the upper two nerves in the brachial plexus (the C5 and C6 nerves) are either damaged or severed. Injury to these nerves results in paralysis and other symptoms in the upper arm. Symptoms of Erb's Palsy include:

Complete paralysis of the upper arm
Inability to rotate from the shoulder
Decreased grip
Numbness in the arm
Atrophy of the arm muscles
Inability to control arm function

Erb's Palsy can be a devastating injury. While some cases will heal over time, severe nerve damages may never heal, resulting in permanent injury and disability.

What is Klumpke's Palsy?

Klumpke's Palsy is similar to Erb's palsy. However, this form of paralysis develops when the two lowest nerves in the brachial plexus (the C8 and T1 nerves) are either damaged or severed. While Erb's Palsy typically affects the shoulder and upper arm, Klumpke's Palsy tends to affect the hand and wrist. Symptoms of Klumpke's Palsy include:

Numbness in the hand or complete loss of feeling
Stiff joints
Atrophy of the hand muscles
A limp hand
Complete paralysis of the hand
Severe pain
Drooping of the eyelids on the side of the face opposite to the affected hand.

Like Erb's Palsy, the length of time a child will suffer from Klumpke's Palsy depends largely on the degree of nerve damages. More extensive damage is likely to cause permanent injury and disability which will require continuing medical intervention and treatment throughout the child's life.

Alvin F. de Levie maintains offices throughout Pennsylvania in Philadelphia, State College, Bellefonte, Lock Haven, and we are willing to meet any clients throughout the Commonwealth. We understand the process of filing any type of medical malpractice case is very stressful and difficult to maneuver alone, that is why we are here to help! Our experienced personal injury lawyer (s) or personal injury attorney (s) stand ready to help!

If your child has suffered from Erb's Palsy or Klumpke's Palsy as a result of a birth injury, The Law Offices of Alvin F. de Levie & Associates can help. Contact a member of our legal team today at (844) 777-2529 for a consultation.

Other inciteful articles:

Why You Should Hire a Personal Injury Lawyer For a Car Accident Case:

Personal Injury Lawyer's Tips For Reducing Childhood Sports Injuries:

CDC and Malpractice Lawyers Warn Patients of Contamination:

Alvin deLevie, Esq.
Law Offices of Alvin F. de Levie
email us here
Visit us on social media:

Source: EIN Presswire

Social Media in the Pharma Industry, are you Listening?

Gain techniques in digital strategies as Jacob Flindt, Founder, presents how to personalise content relationships with artificial intelligence.

LONDON, LONDON, UNITED KINGDOM, October 25, 2018 / — Understanding your audience through digital channels is key in today's healthcare world, as patients are using devices and moving more onto online communications to contact and find information from GP's and industry professionals. The 11th annual Social Media in the Pharmaceutical Industry conference will explore the digital innovations and strategies within pharma and how to keep the patient at the forefront.

Gain techniques in digital strategies as Jacob Flindt, Founder, presents how to personalise content relationships with artificial intelligence. Personalising content to the individual without unnecessary repetition is key to a lasting relationship. He will also examine why the main relationship doctors want with pharma is to feel safe prescribing treatments. AI can capture patterns about each doctor and speed up learning the path to prescriptions.
Jacob will be joined by a panel of Pharma Social Media experts including:

Lin Lei, Associate Director, Digital Customer Engagement, Teva
Roeland van der Heiden, Digital Director, AstraZeneca
Doris Casares, Director, Communication, Corporate Social Responsibility and AZ Foundation, AstraZeneca
Simon Ip, Global Digital Communications Specialist, Global External Communication, LEO Pharma
Stefania Alvino, Multichannel Manager, Daiichi Sankyo
Paul Tunnah, CEO, PharmaPhorum Media
Emma Sutcliffe, Director Patient Engagement and Innovation, NexGen Healthcare Communications
Timos Papagatsias, CEO, LucidQuest

Conference programme highlights include: Optimisation of social media usage amongst pharma companies, social listening: procedures and practices to consider before implementation and congress listening for HCP Insights.

Following on from the main conference on 23rd January, there will be 2 workshops focusing on Social Listening with Node XL and Strategic Digital Pharma Marketing.
Social Media in the Pharmaceutical Industry
Date: 21st – 23rd January 2019


Neill Howard
SMi Conferences
+44 20 7827 6164
email us here

Source: EIN Presswire

The Opioid Crisis Response Act Supports Local Health Department Efforts to Protect Public Health

The National Association of County and City Health Officials (NACCHO) commends the president for signing the Opioid Crisis Response Act into law today.

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, October 24, 2018 / — The National Association of County and City Health Officials (NACCHO), representing nearly 3,000 local health departments, commends the president for signing the Opioid Crisis Response Act into law today. Local health departments are on the front lines of this national public health crisis, and as vital community partners, are working across other sectors including hospital systems, healthcare delivery, mental health and substance abuse, social services, emergency services, and law enforcement, to address opioid misuse.

“NACCHO commends Congress and the president for making this important bill law,” said NACCHO Chief of Government and Public Affairs, Adriane Casalotti, MPH, MSW. “With more than three out of five drug overdoses involving an opioid and tens of thousands dying from opioid misuse, the Opioid Response Act is a critical part of what is needed to address the epidemic. NACCHO is particularly pleased that this bipartisan bill recognizes the value of preventive measures, a core principle of public health practice, and it acknowledges the infectious disease challenges of injection drug use associated with the opioid epidemic. These are complex issues, and we believe a public health approach is the most effective way to deal with this crisis. But there is still more to do to ensure that this federal response to the opioid epidemic reaches local communities. We look forward to working with the Administration to ensure that these federal policies address the needs of the many local health departments who are working each day to curb opioid addiction and save lives.”

Highlights of the Legislation

The bipartisan Opioid Crisis Response Act addresses the following:

• Expands the grant program used to purchase naloxone, which was authorized in the Comprehensive Addiction and Recovery Act (CARA);

• Authorizes the Centers for Disease Control and Prevention (CDC) to work to combat the opioid crisis through data collection, including grants for states, localities, and tribes;

• Creates a CDC grant program to prevent and respond to infections including hepatitis and HIV;

• Allows physicians to prescribe Medication-Assisted Treatment (MAT) for up to 275 patients at any one time;

• Provides the Food and Drug Administration authority to require drug manufacturers to package three- or seven-day supplies; and

• Increases education and training to promote improved prescribing practices.

To learn more about NACCHO’s position on addressing the opioid epidemic, click here.

# # #

The National Association of County and City Health Officials (NACCHO) represents the nation's nearly 3,000 local health departments. These city, county, metropolitan, district, and tribal departments work every day to protect and promote health and well-being for all people in their communities. For more information about NACCHO, please visit

Theresa Spinner
National Association of County and City Health Officials
+1 202-783-5551
email us here

Source: EIN Presswire

Intermountain Healthcare Employees Win Awards For Outstanding Efforts To Improve Patient Experience And Reduce Opioids

Intermountain Healthcare Opioid Tiger Team

SALT LAKE CITY, UTAH, USA, October 24, 2018 / — Caregivers and teams from Intermountain Healthcare hospitals from Ogden to St. George, Utah, and a system-wide team to reduce opioid use were honored with Spirit of Intermountain awards for their efforts to exemplify Intermountain's Fundamentals of Extraordinary Care during a recent meeting of Intermountain's leadership team.

Here's a sampling of how these award-winning caregivers showed extraordinary compassion in both emergency situations and everyday care.

First responder supplies placed in cancer center at Intermountain McKay-Dee Hospital help patients in an emergency

Brittania Doxstader, a critical care tech in the cancer center at Intermountain McKay-Dee Hospital in Ogden, Utah, noticed it takes several minutes for the emergency response team to arrive at the far north end of the hospital with medical supplies when a medical code is called. To solve the problem, she purchased a bag and filled it with medical supplies a first responder would need. She presented the idea to Donna Chapman, RN, and other leaders with a written business plan, a review of the current campus response policy, and a prototype bag. "This is an incredible solution to a problem with the patient at the very center," says Chapman. "Brittania was very proactive in solving a patient safety problem."

Caregiver who delivers meals at The Orthopedic Specialty Hospital recognizes patient’s pre-heart attack symptoms

Michelle DeHaas, health unit coordinator at The Orthopedic Specialty Hospital (TOSH) in Murray, UT routinely delivers meal trays to patients and she takes the responsibility seriously. When she delivered a tray to a patient who was sweating profusely, she went beyond her responsibility to make sure he was all right. Even through though he said he was OK, Michelle notified the care team, and they responded quickly and found the patient was in the early stages of a heart attack. "Michelle took a role that was broader than the task in front of her," says Michael Woodruff, MD. "She stopped after noticing the patient didn't look right and escalated her concern. Because of her quick actions she probably saved this patient's life."

Intermountain Garfield Memorial Hospital team sets up water filtration system after flash flood

After a flash flood contaminated the Panguitch, UT water supply last July — which meant the hospital team was unable to use the city water in any way — Garfield caregivers went to heroic lengths to ensure patients still received the best care. Team members including Nick Frandsen, Justin Woolsey, Steve Ikuta, Eric Wilkinson, Bob Bryant, Alberto Vasquez, Tony Matthew, and DeAnn Brown quickly set up a water filtration system. They planned how to provide meals for all the hospital's patients, caregivers, and long-term care residents. They even seamlessly coordinated laundry services with Intermountain Sevier Valley Hospital. "This team exemplified putting the patient first," says Jeanee Shakespeare, RN. "The spirit of teamwork and doing whatever it takes was at the forefront of their work."

Opioid Tiger Team working to reduce the number of prescribed opioid pills at all Intermountain Healthcare facilities

The Intermountain Opioid Tiger Team came together in early 2018 to drive three system level goals to decrease the number of tablets prescribed for acute conditions by 40 percent, to decrease the co-prescribing of opioids and benzodiazepines by 15 percent, and to increase the number of patients with opioid use disorders treated with buprenorphine by 10 percent. The team has worked to spread opioid abuse-prevention messages to caregivers, patients, and community members — and their efforts were recently recognized at a national Community Anti-Drug Coalition conference. The Opioid Tiger Team includes Frank Nguyen, Heidi Hall, Dave Hasleton, Brad Gillman, Bridget Shears, Steve Hadley, and Lynsie Daley. "Delivering on these goals has been a major lift that truly demonstrated teamwork," says Lisa Nichols, Community Benefit behavioral health director. "This team has significantly influenced both caregiver and patient behavior in support of helping people live the healthiest lives possible."

Dixie Regional Medical Center team helps coordinate end of life care for Korean accident victim

When a Korean woman was in a terrible car accident while on vacation, the Intermountain Dixie Regional Medical Center care management team in St. George, UT came together to ensure she received the best care. They considered the family's cultural needs regarding end-of-life care and figured out how to help them with communication, finances, travel, housing, and emotional support. Interpreters were engaged to ensure the team respected the language of the family and helped provide information to help them make appropriate decisions. The care management team includes Megan Chepkwurui, Colette Paxman, RN, Roger Erickson, LCSW, Victoria Graff, CSW. "This team walks with patients and families during their greatest moments of grief, loss, and life changes. They do so by ensuring the patient and their ideals and goals are at the center of every individual care plan," says Amber Kayembe, case management director.

Family members receive final EKG memento when patients pass away at Intermountain Medical Center

As a way to help comfort the family members of patients who passed away on her unit, Lisa Beglarian, RN, from Intermountain Medical Center in Murray, UT prints out the patient's EKG strip showing their final heartbeat and puts it into a lab tube, along with a thoughtful note for the family. Lisa's idea has been shared with fellow caregivers and they all now use the same practice. Lisa has even worked to collect expired lab tubes, so no resources are wasted. "This is a precious gift for grieving families who have a loved one who has passed away," says coworker Cassie Garcia. "Lisa sets a great example with her empathy."

Intermountain Healthcare is a Utah-based not-for-profit system of 23 hospitals, 170 clinics, a Medical Group with about 2,300 employed physicians and advanced practice clinicians, a health plans group called SelectHealth, and other medical services. Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit

Daron Cowley
Intermountain Healthcare
+1 801-442-2834
email us here

Source: EIN Presswire

Dr. Eliza Parker reveals details of Cadella Medical Spa and Wellness Center's customized facials

Dr. Eliza Parker

Dr. Eliza Parker

Owner of top-rated Chicago medical spa, Cadella, Dr. Eliza Parker shares details of her business's highly popular customized facials.

CHICAGO, ILLINOIS, UNITED STATES, October 24, 2018 / — Popular with clients of all ages, Cadella Medical Spa and Wellness Center's customized facials are designed to cleanse the skin, prevent aging, promote blood circulation, and reduce stress, among many other benefits, according to spa owner and founder, Dr. Eliza Parker. Rejuvenating and detoxifying the skin, customized facials may also be used to treat acne and acne scarring, while simultaneously tightening the skin and helping to eliminate under eye bags and dark circles for a more youthful appearance.

Asked what clients may expect from a customized facial at Cadella Medical Spa and Wellness Center, Dr. Parker reveals that the process typically starts with a comprehensive analysis. From here, she says, most customized facials begin with a deep cleanse, exfoliation, and extractions – helping to clear blocked pores.

"Not every client will require extractions," points out Dr. Parker, "however that's one of the great aspects of a customized treatment, whereby it's truly tailored to the individual."

If an individual's skin is in need of extractions, she says, the process can absolutely be included as part of any customized facial. If not, however, it can be replaced with a more beneficial treatment for the individual.

From here, the process will vary from client to client, based on the customized nature of the treatment. "A client may expect to receive a customized mask and application of one or more corrective serums, for example," reveals Dr. Parker.

Explaining more about the reasoning behind Cadella Medical Spa and Wellness Center's customized facials, the board-certified physician explains that over time, an individual's skin can go through various stages, ranging from dull and dehydrated in appearance, to exhibiting random breakouts of acne. "At Cadella, we offer numerous customized facial treatments targeted to an individual's skin type and condition, and based on their goals for how they'd like their skin to look and feel."

An added benefit of Cadella Medical Spa and Wellness Center's customized facials, Dr. Parker adds, is that she and her team are able to achieve these results often with very little or no downtime.

"Often I'm asked, 'How do I know which facial treatment is right for me?'" reveals Dr. Parker. "I explain to clients that after a skincare consultation and analysis with our esthetician here at Cadella, they'll then both decide together exactly which treatments are best suited to the individual's skin type, and their goals."

Another frequently asked question, Dr. Parker also reveals the length of an average customized facial. "Generally speaking, most facials range from 45 minutes to an hour – convenient enough to fit into daily life, but just long enough for the process to be perfectly relaxing," she points out, wrapping up.

A boutique, full-service medical spa, Dr. Eliza Parker's Cadella Medical Spa and Wellness Center offers what it calls a holistic, patient-centered approach to aesthetic care and wellness in the heart of Chicago.

Eliza Parker, MD is a board-certified physician and founder of Cadella Medical Spa and Wellness Center. A graduate of Harvard University, Dr. Parker trained at Cornell Weill Presbyterian Hospital in New York City. As medical director of Cadella Medical Spa and Wellness Center, Dr. Eliza Parker focuses on lifelong wellness with expertise in non-invasive facial aesthetics, cosmetic injections, laser treatment, and skin rejuvenation.

Terry Moore
Web Presence, LLC
email us here

Source: EIN Presswire

Lymphatic Education & Research Network (LE&RN) marks 20 years at NYC 5K Run/Walk

Walkers cross the finish line at the 2017 NYC #LymphWalk

Walkers at the Brooklyn Bridge #LymphWalk 2017

Walkers at the 2017 NYC #LymphWalk

November 10 #LymphWalk Prospect Park, Brooklyn – two decades of education, research, and advocacy

We are commemorating 20 years of fighting LE and LD through education, research, and advocacy. And this year, the passage of a lymphedema education bill in New York.”

— William Repicci, LE&RN President and CEO

NEW YORK, NY, USA, October 24, 2018 / — LE&RN and its New York State Chapter will host the ninth annual New York Run/Walk to Fight Lymphedema & Lymphatic Diseases on Saturday, November 10, in beautiful Prospect Park, Brooklyn, at the Grecian Shelter (The Peristyle.) While this is the ninth annual event, this is the first 5K Run/Walk in New York in support of LE&RN. A shorter one-mile loop around the lake will also be available.

This year’s New York Run/Walk will be a celebration of the recent passage of a historic lymphedema education bill in New York State – the first of its kind in the nation. In recognition of this important advocacy milestone, LE&RN will honor the work and contributions of legislative aides Gus Ipsen (office of NYS Assemblymember Linda B. Rosenthal) and Meg Brown (office of NYS Senator Martin Golden), who were instrumental in navigating the bill through the legislature in Albany.

“This is a very special event,” said William Repicci, LE&RN President and CEO. “The very first Walk to Fight Lymphedema & Lymphatic Diseases was held in New York in 2010. This year, we have joined the State Chapter in hosting our first true New York 5K Run/Walk and we’ll be commemorating LE&RN’s 20th year of fighting LE (lymphedema) and LD (lymphatic disease) through education, research, and advocacy. What began as a local grassroots’ effort has grown to include State as well as International Chapters. World Lymphedema Day®, launched by LE&RN in 2016, has been recognized by governments around the world. At the New York Run/Walk, we are looking forward to seeing advocates who have been there from the beginning as well as brand new activists who share our goal – cures for lymphedema and lymphatic diseases. The New York Chapter can be particularly proud of its accomplishments over the past year, which includes the passage of a lymphedema education bill in New York State.”

Sign up to run or walk in support of the 10 million Americans and 250 million worldwide who are battling this lymphedemic™ at runners can register here.

Event details and schedule
• Registration/check-in is from 8:30 – 9:30 am
• The Grecian Shelter is between the F, G and Q trains on Parkside Avenue
• Water and snacks will be provided
• T-shirts will be provided, on a first come, first served basis.

LE&RN thanks National Series sponsors Jobst (Premier National Sponsor), Tactile Medical (Presenting Sponsor), BioCompression Systems, Juzo, ImpediMed/L-Dex, Eiger BioPharmaceuticals, Sigvaris, MediUSA, Herantis Phama, L&R USA Inc., LympheDIVAS, and Lympha Press. Local sponsors include Mount Sinai, ShechterCare, and Pandere Shoes.

About LE&RN
Founded in 1998, the Lymphatic Education & Research Network (formerly LRF) is a 501(c)(3) not-for-profit organization whose mission is to fight lymphatic disease and lymphedema through education, research and advocacy. LE&RN provides valuable educational resources for the millions of people who suffer from lymphedema and lymphatic disease. LE&RN fosters and supports research that can deepen the medical community's understanding of the lymphatic system. For more information about lymphatic diseases or the Lymphatic Education & Research Network, please visit or call (516) 625-9675.

Laura Farrell
Lymphatic Education & Research Network
(516) 625-9675
email us here

Source: EIN Presswire

Aspiria acquires LSA’s Employee Assistance Program

MARKHAM, ONTARIO, CANADA, October 24, 2018 / — Mental health and wellness provider Aspiria Corp. has acquired the Employee Assistance Program (EAP) assets of Lidkea Stob and Associates. The acquisition of the St. Catharines, Ontario-based EAP allows Aspiria to further fulfill its strategic expansion plans for Ontario and across Canada.

Aspiria expressed interest in acquiring LSA’s EAP assets with the goal to expand their reach in Ontario’s Golden Horseshoe Area and to support the excellent work LSA was delivering for its existing clientele.

“We are so excited to make LSA’s EAP a part of the Aspiria family,” says Charles Benayon, Founder & CEO, Aspiria. “This transaction allows Aspiria to continue to strengthen our presence in the EAP market and with LSA’s very loyal client base, this opportunity allows us to achieve our strategic goal.”

John Stob, owner of Lidkea Stob and Associates states, “I am at the stage of my life where I was looking for an exit strategy. As the values of our respective companies align closely, and Aspiria will be strengthening its EAP offering to LSA’s clients with innovative, technology-based mental health services, it is a definite win-win-win situation.”

As a result of the acquisition, Aspiria will be maintaining LSA’s clinical network and provide local account management to ensure continuity of service to both LSA and Aspiria’s Ontario clients in the Golden Horseshoe.

About Aspiria Corp.
Aspiria empowers organizations and their people through Employee and Student Assistance Programs and, Specialized Health Solutions. Established in 2003 and in response to market consolidation in the Employee Assistance Program industry, Aspiria has created a unique and innovative service offering to the underserved small and medium-sized EAP market.
Aspiria serves over 500 client organizations, 315,000 employees, students, and their families across Canada and internationally. One-hundred percent Canadian-owned, Aspiria provides niche, quality mental health solutions and superior customer service to its loyal client base.

Mandy Green
Aspiria Corp
+1 905-415-0500
email us here

Source: EIN Presswire

ADAA 2019 Annual Conference: Focusing Research on Improving Treatment Outcomes for Anxiety and Depression – Chicago, IL

Cutting Edge Research to Optimize Treatment Success|Transcending Cultural, Racial, and Socioeconomic Barriers

SILVER SPRING, MARYLAND, UNITED STATES, October 24, 2018 / — SILVER SPRING, MD. (October 24, 2018) — Some of the most pressing problems mental health professionals face center around breaking cultural, racial, and socioeconomic barriers to anxiety and depression treatment. More than 1,400 international researchers and clinicians specializing in anxiety, depression, and related disorders will discuss these and other relevant topics when they convene March 28-31 at the Anxiety and Depression Association of America (ADAA) 2019 Conference at the Sheraton Grand Hotel in Chicago, IL.

“ADAA is the only multidisciplinary professional organization in mental health that engages the world’s leading experts who focus on anxiety, depression, and related disorders. The ADAA annual conference promotes scientific innovation and engages a diverse network of clinicians and basic and clinical anxiety and depression researchers with diverse backgrounds in medicine, psychology, social work, counseling, nursing, neuroscience, genetics, epidemiology, and other disciplines to advance science and new treatments. After four intensive days of learning, sharing and networking, conference attendees leave more connected to their peers and better able to integrate research, practice, and community,” states Dr. Beth Salcedo, ADAA Board President.

Many of the world’s leading experts will participate in more than 150 workshops, symposia, and roundtables and will address depression and a wide range of anxiety disorders including PTSD, OCD, substance abuse, suicide prevention, and more. Sessions will also focus on mindfulness, trauma, mental health apps, alternative therapies, telemental health, veteran-focused therapy, new and novel pharmacotherapies, and culturally sensitive therapy for diverse communities.

Suicide is a top public health problem faced by our society today. ADAA is excited to offer (on Thursday, March 28) a special day long program featuring presentations and an interactive panel discussion by leading experts who will focus on innovative research and clinical topics on suicide prevention. In addition, ADAA will offer a number of “timely topics” for clinicians and the 22nd annual research symposium that presents new developments in stress and inflammation with a focus on inflammatory processes in stress, anxiety, and depression.

Alan Schatzberg, MD, Stanford University School of Medicine’s Professor of Psychiatry and Behavioral Sciences, will deliver the keynote address, “Potential Drugs of Abuse as Antidepressants and Anxiolytics: Pluses and Minuses.” Dr. Schatzberg will review recent data and raise key issues regarding how to balance risk-benefit both for individual patients and society at-large on Thursday, March 28th.

For more details about special session offerings and registration information please visit the ADAA website:

Members of the media can register for the conference by emailing Lise Bram ( or by calling 240-485-1016. Registration is limited to credentialed journalists and journalists who have assignment letters on the letterhead of a media organization. All media personnel must be registered and wear their convention badges while attending any convention session or activity. The conference program will be available online in early March. Printed programs will also be available on site. Selected papers will be available electronically upon request. Media can make hotel reservations online.

The media will have opportunities to interview experts and attend all sessions.

Anxiety disorders affect 40 million adults and one in eight children in the United States. These disorders interfere with daily functioning and can lead to depression, substance use, and suicide. Although highly treatable, only one-third of those struggling with anxiety disorders receive treatment.

Depressive disorders affect about 19 million American adults. More than 50 percent of people diagnosed with depression also have an anxiety disorder. In fact, co-existing anxiety and depression is considered one of the most disabling mental health disorders in the United States.

The Anxiety and Depression Association of America (ADAA) is the leading national nonprofit organization dedicated to promoting the prevention, treatment, and cure of anxiety, depression, and related disorders through education, training and research. Visit

Lise Bram
Anxiety and Depression Association of America (ADAA)
+1 240-485-1016
email us here

Source: EIN Presswire

Immuno-autonomics Video Presented by Inmedix at the 2018 Annual Meeting of the American College of Rheumatology (ACR).

Animation describes the actionable links between the brain, stress and autoimmune disease activity in rheumatoid arthritis (RA).

Stress may act as an essential, yet often unappreciated constituent of autoimmune disease activity.”

— Andrew J Holman MD, CEO, Inmedix

NORMANDY PARK, WA, USA, October 24, 2018 / — Inmedix, the leader in next-generation heart rate variability (HRV) application as an informative diagnostic tool in autoimmune disease, today announced the release of its educational animated video at the 2018 ACR Study Group entitled “Immuno-autonomics: Emerging Diagnostic & Therapeutic Advances in Rheumatology” during the ACR/ARHP Annual Meeting being held October 19-24 at the McCormick Place Convention Center, Chicago, IL.

Immuno-autonomics is a powerful, yet relatively new concept to rheumatologists. The educational video is expected to encourage further conversation about how and why stress – modulated within the brain by the autonomic nervous system (ANS) – can influence human immune function to both positively and negatively impact autoimmune activity, treatment success and even disease prevention(1).

In autoimmune disease, the immune system attacks healthy tissues for reasons which remain unclear. Therapy is applied with various immunosuppressive strategies to reduce this inappropriate attack and potential destruction of joints, skin, kidney, brain, etc. (depending on the specific autoimmune disease). Three of the five top-selling medications worldwide are used by rheumatologists: $16 billion for adalimumab (Humira®, AbbVie), $9 billion for etanercept (Enbrel®, Amgen) and $8 billion for infliximab (Remicade®, J&J, Merck)(2).

In 2002, the ANS-immune connection was first proposed as the “Cholinergic Anti-inflammatory Reflex” in Nature(3) by Kevin J. Tracey MD, President & CEO of the Feinstein Institute for Medical Research, Professor & Director of the Center for Biomedical Science at the Feinstein Institute for Medical Research, and Professor of Molecular Medicine and Neurosurgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. ANS stress intensifies autoimmune disease and can reduce the effectiveness of current autoimmune disease treatments(4).

The educational video was created by Inmedix in collaboration with London-based Random42, the global leader in providing scientific digital solutions to the pharmaceutical and biotech industry with its award-winning medical animation, virtual reality, augmented reality, slide kits, brochures and interactive solutions. The video be viewed at:

“Stress may act as an essential, yet often unappreciated constituent of autoimmune disease activity,” says Andrew J. Holman, MD, Inmedix CEO, rheumatologist and Clinical Associate Professor of Medicine at the University of Washington. “Inmedix is pleased to highlight the cholinergic anti-inflammatory reflex in video format to encourage a broader recognition of potential immuno-autonomic clinical applications to improve the lives of patients with rheumatoid arthritis and other autoimmune diseases.”

About Inmedix, Inc. and its subsidiary, Inmedix UK, Ltd.

Seattle-based biotech/medtech Inmedix, Inc. and its subsidiary Inmedix UK, Ltd. are committed to engaging in world class research to discover innovative solutions for pressing healthcare needs related to the impact of stress, modulated within the brain by the autonomic nervous system (ANS). The Inmedix ANS Neuroscan™ is leading applications of next-generation heart rate variability (HRV) as an informative diagnostic, therapeutic, digital health and health economic tool in autoimmune disease. ANS profile may be the most overlooked element of personalized, precision medicine. Beginning with rheumatoid arthritis (RA), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE), ankylosing spondylitis (AS) and multiple sclerosis (MS) in adults, the company hopes to enhance current therapeutic outcomes through complimentary optimization of individual ANS profile.

1. Koopman FA, Tang MW, Vermeij J, Choi IY, Vervoordeldonk MJ, Gerlag DM, Karemaker JM, Tak PP. Autonomic dysfunction precedes development of rheumatoid arthritis: a prospective cohort study. EBioMedicine 2016;6:231-237.
3. Tracey KJ. The inflammatory reflex. Nature 2002;420:853-859.
4. Van Maanen MA, Vervoordeldonk MJ, Tak PP. The cholinergic ant-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat Rev Rheumatol 2009;22

Rae Marie Gleason
Education Program Director, Inmedix, Inc.
email us here


Source: EIN Presswire

Cloud Pharmaceuticals Wins U.S.-China Health Summit

Don Van Dyke, COO, Cloud Pharmaceuticals

First Place Award displayed in Shanghai

Cloud Pharmaceuticals was selected to travel and present in Chengdu, Sichuan Oct. 14 2018 against 3 other US teams and 5 from China. Cloud took first place.

It was truly a great honor to take first place. Cloud continues to show leadership worldwide to enable pharmaceutical companies to cut 5 to 6 years from the process of early design of novel therapies.”

— Don Van Dyke

RESEARCH TRIANGLE PARK, NC, USA, October 24, 2018 / — Cloud Pharmaceuticals, a finalist in the U.S.-China Health Summit competition, was awarded First Place at the finals in Chengdu, Sichuan, China October 14, 2018.

As a key forum for promoting exchange in the health field, the Summit has been alternately hosted by U.S. and China, receiving continuous support from The National Health and Family Planning Commission of China and the U.S. Department of Health and Human Services.

Don Van Dyke, Cloud's Chief Operating Officer, made the winning presentation at The 8th US-China Health Forum, held at the Jinjian Grand Hotel October 12-14. He said, "It was truly a great honor to be selected from the group of finalists from the US and China. Cloud continues to show leadership worldwide to enable pharmaceutical companies to cut 5 to 6 years from the process of early design of novel therapies." The award further solidifies Cloud Pharmaceuticals' leadership in adoption of their technology worldwide.

Cloud Pharmaceuticals is a leader in the burgeoning field of Artificial Intelligence based drug discovery. The company partners, designs, develops, and licenses novel drug compounds for a wide range of medical indications to the pharmaceutical, biotechnology and medical research markets.

The company launched in 2011 with a technology license from Duke University, and has since expanded through early stage funding arrangements from Microsoft, the National Science Foundation, and the University of Florida via its Gatorade royalty fund, and has more recently established a long-term collaboration with Glaxosmithkline (“GSK”).

Since its inauguration in 2011 at Harvard University, the U.S.-China Health Summit (the Summit) has been dedicated to advancing global health by promoting exchange of knowledge, ideas and experiences among current and future health sector leaders from China, the U.S. and other countries. The annual Summit has been held alternately in the U.S. and China which gathers together hundreds of leaders from academia, governmental and non-governmental organizations as well as industry to discuss important challenges and opportunities in health sector reforms and development.

Cloud Pharmaceuticals, Inc.
+1 984-329-2388
email us here
Visit us on social media:

Source: EIN Presswire